FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2. (17th June 2021) - Coutre, S. E.; Barr, P. M.; Owen, C.; Robak, T.; Tedeschi, A.; Bairey, O.; Burger, J. A.; Hillmen, P.; Devereux, S.; Grosicki, S.; McCarthy, H.; Li, J.; et al.